Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 2, March-April, p. 289–296

doi: 10.17219/acem/40452

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Motor Cortex Stimulation in Patients with Chronic Central Pain

Paweł Sokal1,A,B,C,D,E,F, Marek Harat1,B,E, Piotr Zieliński1,E, Jacek Furtak1,E, Darek Paczkowski1,E, Marcin Rusinek1,E

1 Department of Neurosurgery, Military Research Hospital, Bydgoszcz, Poland


Background. Motor cortex stimulation is one of the neuromodulation methods of treating refractory central neurogenic pain.
Objectives. . The aim of this study was to retrospectively evaluate the effects of motor cortex stimulation.
Material and Methods. The study group consisted of 14 consecutive patients with thalamic pain, atypical facial pain, post-brachial plexus avulsion injury pain, phantom pain and pain in syringomyelia who were treated with motor cortex stimulation at the Department of Neurosurgery of the Military Research Hospital in Bydgoszcz, Poland, from 2005 to 2013. The procedures were conducted with the use of neurosurgical navigation and intraoperative neurophysiological monitoring. The outcomes were assessed in terms of visual analog scale scores. The long-term follow-up ranged from one to six years.
Results. A statistically significant reduction in the intensity of pain was noted in patients treated with motor cortex stimulation (pre-surgery median visual analog scale = 9, short-term result median visual analog scale = 3, p = 0.0009; long-term result median visual analog scale = 5, p = 0.0036). Over the long term, with follow-ups ranging from one to six years, the results were excellent (over 80% reduction in pain) in 31% of the patients and satisfactory (50–80% reduction in pain) in 23% of the patients. Unsatisfactory pain control (less than 50%) was noted in 31% of the patients and no improvement was noted in 15%. Significantly better relief of pain was observed in the early postoperative period. In this series of patients, the highest efficacy of motor cortex stimulation was observed in post-stroke or post-hemorrhagic thalamic pain (5/7 patients – 71%). Long-term outcomes were not related to the age or sex of the patient, the preoperative duration of the pain, or to the position or number of implanted electrodes.
Conclusion. MCS significantly reduces the intensity of neurogenic pain. The best long-term results in the present study were achieved in patients with thalamic syndrome. No significant predictors were found for a successful final outcome. The authors consider appropriate selection of patients, accurate placement of the electrodes and frequent adjusting of the stimulation parameters to be important factors increasing the efficacy of MCS.

Key words

motor cortex stimulation, chronic pain, neurogenic pain.

References (23)

  1. Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S: Chronic motor cortex stimulation for the treatment of central pain. Acta Neurochir 1991, 52, 137–139.
  2. Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S: Chronic motor cortex stimulation in patients with thalamic pain. J Neurosurg 1993, 78, 393–401.
  3. Katayama Y, Yamamoto T, Kobayashi K, Kasai M, Oshima H, Fukaya C: Motor cortex stimulation for poststroke pain: comparison of spinal cord and thalamic stimulation. Stereotact Funct Neurosurg 2001, 77, 183–186.
  4. Meyerson BA, Lindblom U, Linderoth B, Lind G, Herregodts P: Motor cortex stimulation as treatment of trigeminal neuropathic pain. Acta Neurochir 1993, Suppl 58, 150–153.
  5. Monsalve GA: Motor cortex stimulation for chronic neuropathic facial pain: A review of the literature. Int Surg Neurol 2012, 3 (Suppl 4), 290–311.
  6. Droutot X, Nguyen JP, Peschanski M, Lefaucheur JP: The antalgic efficacy of chronic motor cortex stimulation is related to sensory changes in the painful zone. Brain 2002, 125, 1660–1664.
  7. Lazorthes Y, Sol JC, Fowo S, Roux FE: Motor cortex stimulation for neuropathic pain. Acta Neurochir Suppl 2007, 97 (Pt 2), 37–44.
  8. Nguyen JP, Keravel Y, Feve A, Uchiyama T, Cesaro P, LeGuerinel C, Pollin B: Treatment of deafferentation pain by chronic stimulation of the motor cortex: report of a series of 20 cases. Acta Neurochir 1997, 68, 54–60.
  9. Nguyen JP, Lefaucher JP, Le Guerinel C: Motor cortex stimulation in the treatment of central and neuropathic pain. Arch Med Res 2000, 31, 263–265.
  10. Wasner G: Central Pain Syndromes. Curr Pain Headache Rep 2010, 14, 489–496.
  11. Velasco M, Velasco F, Brito F, Velasco AL, Nguyen JP, Marquez I: Motor cortex stimulation in the treatment of deafferentation pain. I. Localization of the motor cortex. Stereotact Funct Neurosurg 2002, 79, 146–167.
  12. Fontaine D, Hamani C, Lozano A: Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. J Neurosurg 2009, 110, 251–256.
  13. Thomas L, Bledsoe JM, Stead M, Sandroni P, Gorman D, Lee KH: Motor cortex and deep brain stimulation for the treatment of intractable neuropathic face pain. Curr Neurol Neurosci Rep 2009, 9, 120–126.
  14. Garcia-Larrea L, Peyron R: Motor cortex stimulation for neuropathic pain: From phenomenology to mechanisms. Neuroimage 2007, 37, 71–79.
  15. García-Larrea L, Peyron R, Mertens P, Gregoire MC, Lavenne F, Le Bars D, Convers P, Mauguière F, Sindou M, Laurent B: Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain 1999, 83, 259–273.
  16. Ząbek M, Slawek J, Harat M, Koszewski W, Opala G, Friedman A: Stimulation of the brain and spinal cord to treat movement disorders and pain syndromes – theoretical and practical recommendations. Neurol Neurochir Pol 2006, 40, 1–9.
  17. Henderson J: Intracranial Neurostimulation for Pain Control. Pain Physician 2010, 13, 157–165.
  18. Nguyen JP, Lefaucheur JP, Decq P: Chronic motor cortex stimulation in the treatment of central and neuropathic pain: Correlations between clinical, electrophysiological and anatomical data. Pain 1999, 82, 245–251.
  19. Radic J, Beauprie I, Chiasson P: Motor Cortex stimulation for neuropathic pain syndromes: a multicentre prospective randomized blinded crossover trial. Neuromodulation 2012, 15, 156.
  20. Henderson J, Boongrid A, Rosenow JM, Lapresto E, Rezai AR: Recovery of pain control by intensive reprogramming after loss of benefit from motor cortex stimulation for neuropathic pain. Stereotact Funct Neurosurg 2004, 82, 207–213.
  21. Tanei T, Kajita Y, Noda H, Takebayashi S, Nakatsubo D, Maesawa S, Wakabayashi T: Efficacy of motor cortex stimulation for intractable central neuropathic pain: comparison of stimulation parameters between post-stroke pain and other central pain. Neurol Med Chir (Tokyo) 2011, 51, 8–14.
  22. Lefaucheur JP, Ménard-Lefaucheur I, Goujon C, Keravel Y, Nguyen JP: Predictive Value of rTMS in the Identification of Responders to Epidural Motor Cortex Stimulation Therapy for Pain. J Pain 2011, 12, 1102–1111.
  23. Nuti C, Peyron R, Garcia-Larrea L, Brunon J, Laurent B, Snidou M, Mertens P: Motor cortex stimulation for refractory neuropathic pain: Four year outcome and predictors of efficacy. Pain 118, 43–52.